Terms: = Uterine cancer AND uPA AND Clinical Outcome
1 results:
1. Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer.
Fredstorp-Lidebring M; Bendahl PO; Brünner N; Casslén B; Högberg T; Långström-Einarsson E; Willén R; Fernö M
Eur J Cancer; 2001 Dec; 37(18):2339-48. PubMed ID: 11720826
[TBL] [Abstract] [Full Text] [Related]
